Every year, around 33,200 people are diagnosed with cancer in Scotland*. The same amount of people could fill Glasgow’s OVO Hydro to capacity more than twice over. So, research into the best ways to prevent, diagnose and treat the disease has never been more vital. But it requires funding.
Cancer Research UK’s pioneering work across the UK, including in Scotland, benefits from the generosity of supporters leaving a gift to Cancer Research UK in their Will. In fact, legacy gifts fund a third of its research.
Laura Rooney is a research nurse funded by Cancer Research UK based in Glasgow, she said: “Gifts left in Wills to Cancer Research UK are absolutely essential to what I do. They enable me to work clinically and support patients participating in trials. It means I can also facilitate patient and public involvement, as well as provide education and training to non-research staff around clinical trials, so they can understand the changing face of cancer care.
“I have had close family and friends affected by cancer in the last few years. I have seen first-hand the complete devastation a cancer diagnosis can bring and also the massive benefit of new treatments as a result of research,” Laura added.
“The funding from gifts in Wills is essential to continue researching new potential treatments and to provide treatment options and hope to millions of cancer patients worldwide. I am very grateful to those who leave a gift in their will to help benefit others.”
In 2020/21, Cancer Research UK spent nearly £30m on world-leading research right here in Scotland.
Scotland is home to the Cancer Research UK Scotland Centre, based in Edinburgh and Glasgow, as well as the prestigious Cancer Research UK Beatson Institute in Glasgow. Its researchers in these locations have expertise across a broad range of research areas and cancer types, including bowel and pancreatic cancer.
The scientists in Edinburgh also have expertise in brain tumor research and many are part of the Cancer Research UK Brain Tumor Center of Excellence – a joint initiative between the University of Edinburgh and University College London.
Gifts in Wills are vital because they help enable long-term research projects that could ultimately lead to new treatments for cancer. They allow Cancer Research to keep on making progress and continue to help people live longer, healthier lives for generations to come.
Funding from gifts in Wills means a lot to researchers like Laura, she said: “I’m immensely grateful to all those who leave a legacy in their Will, to help us continue supporting vital work to find the best ways to prevent, detect and treat those affected by cancer.”
2022 marks 20 years since Cancer Research UK was formed. In that time, huge strides have been made together. It has come so far and will go much further.
Laura has high hopes for the future of cancer treatment: “I hope that in the future no-one has to be afraid when they hear the word cancer, and that we have a treatment option available for everyone facing a cancer diagnosis.”
5,561*** supporters in Scotland have pledged to leave a gift in their Will to Cancer Research UK. Join with them to help fund pioneering researchers like Laura and make cancer as we know it a thing of the past.
Together we will beat cancer.
To get your free Gifts in Wills guide, visit cruk.org/pledgescotland.
*Based on the annual number of new cases of all cancers combined excluding non-melanoma skin cancer (ICD10 C00-C97 excluding C44) diagnosed in the East Midlands Region of England in 2019. Source: NCRAS (part of NHS Digital) Cancer registration statistics , England, 2019.
**Ahmad AS et al. British Journal of Cancer, 2015
***This figure relates to all gifts in Wills from this area up to 2019/20
George Holan is chief editor at Plainsmen Post and has articles published in many notable publications in the last decade.